AVI Polymers share price hits upper circuit: FY26 board cues

Stock locks in repeated upper circuits

AVI Polymers Ltd, a small-cap stock with a market capitalisation of ₹127.39 crore, stayed in focus after hitting upper circuits across multiple sessions. The stock has seen a 5% upper circuit repeatedly since April 13, according to the updates cited in the report. On Monday, the share price rose as much as 5% to ₹13.54 apiece on the BSE, marking the fourth straight session of upper circuit in one snapshot. In another trading update from the same day, the stock was reported locked at a 5% upper circuit at 1:56 PM on April 20, 2026, following the company’s board meeting intimation. A separate Hindi-language update also cited the stock at ₹17.97, up 5% (₹0.85) by 11:32 AM, underscoring the volatility and multiple price snapshots referenced across the coverage.

What triggered the buying interest

The buying momentum was linked to multiple corporate developments disclosed through exchange filings. The company said it has called a Board of Directors meeting on April 27, 2026. The agenda includes consideration of financial results and a proposal that may include a dividend recommendation. The board will also consider an expansion plan into the “high-growth Healthcare Technology sector,” as per the article. In addition, the company has talked about executing an expansion through its subsidiary, AVI AI Technologies, positioning it as the next step toward an AI-driven digital ecosystem.

April 27 board meeting: results, dividend, and strategy

The April 27, 2026 board meeting is the key near-term event highlighted. The board is expected to consider results (as mentioned in the report) and may recommend a dividend of up to 50% on the paid-up equity share capital for FY2025-26. The same meeting agenda also includes a decision on moving into the Healthcare Technology segment. These elements together created a fresh set of catalysts for a stock that has frequently been described as “circuit-to-circuit” in the coverage.

Volume spike adds to the momentum

Trading activity also strengthened the day’s move. Around 58 lakh equity shares of AVI Polymers reportedly changed hands on exchanges, far higher than the one-month average volume of about 12 lakh shares. The article linked the rally to “strong trading volumes” alongside the corporate actions. For penny and micro-cap counters, such volume surges often coincide with sharp price moves and quicker sentiment shifts, which is consistent with the stock’s repeated upper circuit references in the report.

Q3 FY26 numbers: sharp quarter-on-quarter jump

AVI Polymers’ Q3 FY26 performance was presented as a major trigger behind improved sentiment. The company reported a Q3 FY26 net profit of ₹7.02 crore, compared with ₹2.29 crore in Q2 FY26, a 206% quarter-on-quarter increase. Revenue from operations rose to ₹132.32 crore in Q3 FY26, from ₹29.50 crore in Q2 FY26, reflecting 348% growth QoQ. The coverage also quoted the managing director, Chintan Patel, saying Q3 FY26 marked an important turnaround, attributing it to better execution, strict cost control, and momentum returning to the business.

Nine-month FY26 performance and what it signals

For the nine-month period of FY26, AVI Polymers reported net profit of ₹10.09 crore and revenue from operations of ₹161.82 crore, based on figures in the report. The nine-month numbers were described as showing cumulative improvement and supporting the narrative of operational recovery. While the report did not provide year-on-year comparisons, it framed the quarter-on-quarter jump as a key reason behind the renewed market interest.

Rights issue approval and capital structure changes

The company has also received in-principle approval from the BSE for a proposed ₹90 crore rights issue, dated January 06, 2026, as cited. The report said this approval allows the company to move ahead with fundraising subject to regulatory and compliance requirements. Another update stated that the board had approved fundraising up to ₹90 crore through a rights issue of equity shares with face value ₹10 to eligible shareholders. The company also indicated the proceeds would be used to strengthen working capital, increase trading volumes, and invest in new business opportunities.

Push into AI and product launches

Apart from the healthcare technology plan, the report also referenced a separate corporate development: the launch of ‘KrishiBuddy’. AVI Polymers’ share price hit a 5% upper circuit on Wednesday after the company announced the launch of KrishiBuddy, an AI-powered smart farming platform developed by its wholly owned subsidiary, AVI Eco Spark. Features listed included multilingual support, crop-health monitoring, financial planning tools, pest alerts, and export calculators. The launch was positioned as part of a broader push into technology-led opportunities.

Price performance: multiple snapshots, sharp swings

The article provided several return snapshots over different periods, highlighting volatility. One set of figures said the stock had fallen 37% in one month, but rallied 82% in three months, jumped 125% in six months, and rallied 114% in one year, with 195% returns over two years and 273% over five years. Another set described the stock as down 18% over one month, up 29% in three months, up 15% in six months, and up 37% over one year, while also stating “253% returns in the past one year.” Separate trading snapshots also cited the share price at ₹12.27 (up ₹0.58), and another update said the stock was at ₹18.86 on February 3, 2026, after rising 4.95% and hitting upper circuit, with EPS of ₹7.46 and P/E around 2.53. The report also cited different 52-week ranges across sources, including ₹4.36 to ₹15.25, and ₹9.89 to ₹34.57.

Key facts at a glance

Why the developments matter for investors

The sequence of updates ties together three themes that typically drive near-term action in small-cap counters: sharp quarterly improvements, corporate actions such as fundraising, and event-driven triggers like board meetings. In AVI Polymers’ case, the April 27 meeting agenda combines financial results, a potential dividend proposal, and a strategic expansion into Healthcare Technology. The rights issue approval adds another layer, as it outlines potential funding for working capital and growth. At the same time, the stock’s wide range of price and return snapshots in the report underlines how quickly sentiment can change around such announcements.

Conclusion

AVI Polymers’ upper-circuit streak has been linked to a mix of strong Q3 FY26 numbers, a pending dividend proposal of up to 50%, and a board-level review of expansion into healthcare technology. The next key milestone is the April 27, 2026 board meeting, where decisions on results, dividend recommendation, and strategic expansion are expected to be considered, as per the company’s filing referenced in the report.